Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2012
DOI: 10.1016/j.jaci.2012.01.056
|View full text |Cite
|
Sign up to set email alerts
|

Increasing the accuracy of peanut allergy diagnosis by using Ara h 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
194
1
6

Year Published

2013
2013
2017
2017

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 219 publications
(213 citation statements)
references
References 16 publications
12
194
1
6
Order By: Relevance
“…The analysis of ImmunoCAP ISAC data revealed that 4 of them were sensitized to CCDs and 2 of those 4 were sensitized to profilins, but the remaining 3 subjects showed no sensitization to allergens with potential cross-reactivity to peanut. This observation, also reported by others [11,14,18], indicates that additional peanut allergens might be implicated in peanut hypersensitivity in these patients. Although the peanut oleosins (Ara h 10, Ara h 11), peanut defensins (Ara h 12, Ara h 13) and an additional 2S albumin (Ara h 7) have been identified as allergens, data about their clinical relevance for peanut-allergic patients are very scarce [25], suggesting that large-scale studies to evaluate the sensitization patterns to these components in peanut-allergic patients are required.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…The analysis of ImmunoCAP ISAC data revealed that 4 of them were sensitized to CCDs and 2 of those 4 were sensitized to profilins, but the remaining 3 subjects showed no sensitization to allergens with potential cross-reactivity to peanut. This observation, also reported by others [11,14,18], indicates that additional peanut allergens might be implicated in peanut hypersensitivity in these patients. Although the peanut oleosins (Ara h 10, Ara h 11), peanut defensins (Ara h 12, Ara h 13) and an additional 2S albumin (Ara h 7) have been identified as allergens, data about their clinical relevance for peanut-allergic patients are very scarce [25], suggesting that large-scale studies to evaluate the sensitization patterns to these components in peanut-allergic patients are required.…”
Section: Discussionsupporting
confidence: 87%
“…Our findings confirm observations from other peanut CRD studies that have demonstrated that this allergen panel enables the majority of peanut-allergic patients to be identified [1,18]. However, although the peanut extract was absolutely discriminative between patients with suspected peanut allergy and nonatopic controls, a positive sIgE result for peanut extract did not reflect the clinical relevance as it was also found in 75% of individuals without an apparent peanut allergy.…”
Section: Discussionsupporting
confidence: 75%
“…In Japan, Ebisawa et al [9] found that measurement of Ara h 1-, 2-, and 3-specific immunoglobulin E (IgE) antibodies was useful for the diagnosis of peanut allergy in Japanese children and that rAra h 2 ImmunoCAP testing was able to differentiate between peanut-allergic and asymptomatic peanut-sensitized children, similar to studies from Western countries [10,11,12]. Component-resolved diagnosis of PA in Taiwan also showed that Ara h 1-3 were the major peanut allergens in local patients, and peanut-allergic children had persistent elevation of Ara h 2-specific IgE [13].…”
Section: Introductionmentioning
confidence: 83%
“…Так, сенсибилизация к аллергену арахиса rAra h2 в Европе среди пациентов детского возраста составляет более 60% и является ключевым маркером аллергических реакций к арахису [14][15][16].…”
Section: результаты и обсуждениеunclassified